Tenax Therapeutics Analyst Ratings
Tenax Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Tenax Therapeutics (TENX) rating was a reiterated with a price target of $0.00 to $6.00. The current price Tenax Therapeutics (TENX) is trading at is $0.61, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/13/2023 | 890.59% | Roth MKM | → $6 | Reiterates | Buy → Buy |
| 03/07/2023 | 890.59% | Roth MKM | → $6 | Initiates Coverage On | → Buy |
| 12/29/2020 | 725.49% | HC Wainwright & Co. | → $5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/13/2023 | 890.59% | Roth MKM | → 6 美元 | 重申 | 購買 → 購買 |
| 03/07/2023 | 890.59% | Roth MKM | → 6 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 12/29/2020 | 725.49% | HC Wainwright & Co. | → 5 美元 | 啓動覆蓋範圍開啓 | → 購買 |
What is the target price for Tenax Therapeutics (TENX)?
Tenax Therapeutics（TENX）的目標價格是多少？
The latest price target for Tenax Therapeutics (NASDAQ: TENX) was reported by Roth MKM on November 13, 2023. The analyst firm set a price target for $6.00 expecting TENX to rise to within 12 months (a possible 890.59% upside). 2 analyst firms have reported ratings in the last year.
羅斯MKM於2023年11月13日公佈了Tenax Therapeutics（納斯達克股票代碼：TENX）的最新目標股價。該分析公司將目標股價定爲6.00美元，預計TENX將在12個月內升至12個月內（可能上漲890.59％）。去年有兩家分析公司公佈了評級。
What is the most recent analyst rating for Tenax Therapeutics (TENX)?
Tenax Therapeutics（TENX）的最新分析師評級是多少？
The latest analyst rating for Tenax Therapeutics (NASDAQ: TENX) was provided by Roth MKM, and Tenax Therapeutics reiterated their buy rating.
Roth MKM提供了Tenax Therapeutics（納斯達克股票代碼：TENX）的最新分析師評級，Tenax Therapeutics重申了買入評級。
When is the next analyst rating going to be posted or updated for Tenax Therapeutics (TENX)?
Tenax Therapeutics（TENX）的下一次分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenax Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenax Therapeutics was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Tenax Therapeutics的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Tenax Therapeutics的最新評級是在2023年11月13日公佈的，因此您應該預計下一個評級將在2024年11月13日左右公佈。
Is the Analyst Rating Tenax Therapeutics (TENX) correct?
分析師對Tenax Therapeutics（TENX）的評級是否正確？
While ratings are subjective and will change, the latest Tenax Therapeutics (TENX) rating was a reiterated with a price target of $0.00 to $6.00. The current price Tenax Therapeutics (TENX) is trading at is $0.61, which is within the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但Tenax Therapeutics（TENX）的最新評級得到了重申，目標股價爲0.00美元至6.00美元。Tenax Therapeutics（TENX）目前的交易價格爲0.61美元，在分析師的預測區間內。
